CP-461 for the Treatment of Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

September 30, 2003

Conditions
Crohn's Disease
Interventions
DRUG

CP-461

Trial Locations (10)

11021

Long Island Clinical Research Associates, LLP, Great Neck

21044

Digestive Disease Associates, PA, Columbia

30342

Atlanta Gastroenterology Associates, Atlanta

32607

Florida Medical Research Institute, PA, Gainesville

35211

Southern Drug Research, Birmingham

46237

Indianapolis Gastroenterology and Hepatology, Inc., Indianapolis

60637

University of Chicago Medical Center, Chicago

92868

Community Clinical Trials, Orange

95219

Consultants for Clinical Research, Inc., Cincinnati

08234

Atlantic Gastroenterology Associates, Egg Harbor

Sponsors
All Listed Sponsors
collaborator

Cell Pathways

INDUSTRY

collaborator

OSI Pharmaceuticals

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00042055 - CP-461 for the Treatment of Crohn's Disease | Biotech Hunter | Biotech Hunter